↓ Skip to main content

Dove Medical Press

Axitinib in the treatment of renal cell carcinoma: design, development, and place in therapy

Overview of attention for article published in Drug Design, Development and Therapy, September 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

patent
2 patents
wikipedia
1 Wikipedia page

Citations

dimensions_citation
57 Dimensions

Readers on

mendeley
79 Mendeley
Title
Axitinib in the treatment of renal cell carcinoma: design, development, and place in therapy
Published in
Drug Design, Development and Therapy, September 2017
DOI 10.2147/dddt.s109640
Pubmed ID
Authors

Audrey Bellesoeur, Edith Carton, Jerome Alexandre, Francois Goldwasser, Olivier Huillard

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 79 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 79 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 16%
Student > Bachelor 9 11%
Other 9 11%
Student > Ph. D. Student 9 11%
Student > Doctoral Student 4 5%
Other 12 15%
Unknown 23 29%
Readers by discipline Count As %
Medicine and Dentistry 21 27%
Pharmacology, Toxicology and Pharmaceutical Science 10 13%
Biochemistry, Genetics and Molecular Biology 9 11%
Chemistry 4 5%
Agricultural and Biological Sciences 3 4%
Other 7 9%
Unknown 25 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 April 2021.
All research outputs
#3,799,858
of 25,382,440 outputs
Outputs from Drug Design, Development and Therapy
#249
of 2,268 outputs
Outputs of similar age
#65,204
of 324,453 outputs
Outputs of similar age from Drug Design, Development and Therapy
#3
of 46 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 324,453 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.